The αβ T-cell coreceptor CD4 enhances immune responses more than 1 million-fold in some assays  and yet the affinity of CD4 for its ligand  peptide-major histocompatibility class II (pMHC II) on antigen-presenting cells  is so weak that it was previously unquantifiable